ReviewCurrent treatment options in oncology2017

Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms.

Ahmed Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.